News from oramed pharmaceuticals inc

Jun 23, 2014, 08:15 ET

Oramed Pharmaceuticals to Present at the BIO International Convention in San Diego

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Jun 10, 2014, 08:15 ET

Oramed Pharmaceuticals to Present at the American Diabetes Association 74th Scientific Sessions on June 13 - 17, 2014 in San Francisco

  Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development...

May 29, 2014, 12:00 ET

Oramed Pharmaceuticals Added to the Morgan Stanley Capital International (MSCI) MicroCap Index

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

May 27, 2014, 08:15 ET

Oramed to Present at Jefferies Global Healthcare Conference on June 2 in New York City

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug...

May 19, 2014, 07:00 ET

Oramed Pharmaceuticals to Present at the IATI Israel Innovation Conference in Tel Aviv

  Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP), a clinical-stage developer of oral delivery systems, announced today that Josh Hexter,...

May 13, 2014, 13:10 ET

Oramed to Present Poster on its Oral Insulin Capsule at the Yale Diabetes Symposium

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Apr 24, 2014, 14:30 ET

Oramed Pharmaceuticals Presents Data from Phase IIa Trial with ORMD-0801 in Type 2 Diabetes at the 2014 Diabetes Summit

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug...

Apr 10, 2014, 08:10 ET

Oramed Granted Patent in Hong Kong for Oral Administration of Insulin

 Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug...

Mar 27, 2014, 08:45 ET

Oramed Pharmaceuticals Announces First Patient Enrolled in a US Phase 2a Trial for ORMD-0801 in Treatment of Type 1 Diabetes

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Mar 11, 2014, 08:30 ET

Oramed Granted its 3rd Patent in Australia for Oral Administration of Exenatide

 Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of...

Mar 06, 2014, 08:20 ET

Oramed to Present at Upcoming Conferences

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Mar 03, 2014, 08:20 ET

Oramed to Present Results from its Phase 2a FDA Trial with ORMD-0801 at the 2014 Diabetes Summit on April 24, 2014

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Feb 10, 2014, 09:47 ET

Oramed Submits Phase 2a Protocol to FDA for the Treatment of Type 1 Diabetes with its Oral Insulin Capsule

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug...

Jan 30, 2014, 04:00 ET

Oramed Announces Successful FDA Phase 2a Clinical Trial Results

 Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP), a developer of oral drug delivery systems, announced today results from its Phase 2a clinical...

Jan 27, 2014, 09:10 ET

Oramed to Announce Results of its Phase 2a Clinical Trial for Oral Insulin on January 30th at the Tel Aviv Stock Exchange

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it will...

Jan 02, 2014, 08:20 ET

Oramed Receives Patent Allowance in Israel and Australia for Platform Technology in Oral Delivery of Proteins

 Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it...

Dec 24, 2013, 21:12 ET

Oramed to Raise $15,800,000 in Registered Direct Offering

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP), a developer of oral drug delivery systems, today announced that it has entered into definitive...

Dec 20, 2013, 07:30 ET

Oramed Announces Successful Results from Ex-US Pharmacokinetic Study of its Oral Insulin for the Treatment of Type 1 Diabetes

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug...

Dec 10, 2013, 10:37 ET

Oramed Receives Allowance on its Core Oral GLP-1 Technology Patent in Israel

Oramed Pharmaceuticals Inc. (NASDAQCM:ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Nov 19, 2013, 09:57 ET

Oramed Receives Patent in the European Union for the Oral Delivery of Insulin

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a developer of oral drug delivery systems, announced today that the European Patent...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer